INSIGHTS ON QUALITY CONTROL
-
Understanding cGMPs For Phase 1 Investigational Drugs
Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.
-
Adapting To Evolving Needs: How Modular Cleanrooms Enhance Safety In Pharmaceutical Manufacturing
High-potency therapies demand stringent containment and worker safety. Discover how scalable, modular infrastructure simplifies compliance and protects product integrity in regulated facilities.
-
Ophthalmic Drug Delivery: Meeting Modern Challenges With A Next Generation Solution
Ophthalmic injectable packaging demands early strategic attention. Learn how silicone oil contamination, particulate limits, and dosing accuracy challenges can derail development programs and what it takes to stay compliant.
-
6 Trends Redefining Biologics Manufacturing In 2026
Biologics manufacturing is evolving through smarter fill technologies, onshoring, advanced automation, and data driven processes that improve efficiency, reduce risk, and protect product value.
-
Eliminate Variability, Accelerate Results: Value Of Ready-To-Use Reagents10/15/2026
Pre-made solutions reduce operator variability, save bench time, and lower contamination risk by eliminating reagent preparation and reducing handling.
-
Is Your Water Undermining Your Results?10/15/2026
Water is often chosen by availability rather than application. Defining it as a controlled process parameter targets a variability source that routinely escapes root cause analysis.
-
Evaluation Of Novel Process Indicators For Hydrogen Peroxide Decontamination6/30/2026
Immediate, quantifiable verification replaces seven-day incubation periods. Discover how enzyme-based indicators optimize hydrogen peroxide decontamination.
-
What Is LearnGxP?4/24/2026
Stop the cycle of "click-through coma" in GXP training. Discover how scenario-based learning and role-specific curricula reduce compliance risks and drive meaningful engagement.
-
Building Resilience Into Your Analytical Testing Strategy9/15/2026
Building redundancy into testing helps avoid delays and supply risks. Qualified third-party labs provide flexible capacity, smooth transfers, and reliable batch release.
QUALITY CONTROL SOLUTIONS
-
Scaling organometallic reactions requires robust cryogenic infrastructure and precise reagent preparation. Standardized facilities support seamless tech transfer, safe scale-up, and reliable supply.
-
Unlock higher yields and ensure regulatory success with a tailored process optimization program designed to eliminate contamination risks and stabilize biopharmaceutical workflows.
-
Bioburden testing and microbial limit testing are quality control tests for determining the total number of viable microorganisms of pharmaceutical and medical products. Thanks to its many cleverly designed features, the Milliflex Oasis® is a particularly productive and reliable membrane filtration method for performing bioburden testing in accordance with USP, EP, and JP recommendations, ensuring that patients can call upon microbially safe products.
-
The pharmaceutical industry continues to bring breakthroughs in the field of new vaccines and drug delivery systems amidst the increased scrutiny of the regulators. The packaging acts as the primary sterile barrier in drug delivery systems that safeguard the drug product through its life cycle. The efficiency of the primary sterile barrier and the functional components are of utmost importance to patient safety.
-
Safeguard controlled environments with pre-saturated sporicidal wipes that eliminate mixing errors. Achieve rapid, EPA-approved disinfection during critical material transfers.